Answers are grounded in this paper and cite their sources.
Matched case-control analysis shows no heightened malignancy risk in pemphigoid patients, suggesting standard cancer screening is adequate.
The association between pemphigoid and malignancy remains controversial. In a national matched case-control analysis of the NIH All of Us database, encompassing 249 pemphigoid patients and 1,238 matched controls, we found no significant increase in hematologic, solid organ, or nonmelanoma skin cancer risk among patients with pemphigoid. These findings suggest that routine enhanced cancer screening beyond standard age-appropriate recommendations may not be warranted solely because of pemphigoid.
No takes yet. Share an insight, caveat, or question.
Pathak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: